Carterra is a company providing technologies for the discovery of therapeutic candidates. It offers LSA, an instrument for monoclonal antibody (mAb) screening and characterization that combines microfluidics technology with real-time high throughput surface plasmon resonance, kinetic and epitope analysis, and visualization software.